Navigation Links
Depomed Announces Appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer
Date:7/16/2014

d our franchise in pain and central nervous system diseases."

"I am extremely pleased to be joining Depomed at this exciting time in the company's history," said Dr. Rao.  "I believe that Jim and the team at Depomed have accomplished a tremendous amount in the past few years and continue to move towards a leadership position in the field of pain and CNS related products.  I look forward to helping the company achieve that goal."

About Depomed

Depomed is a specialty pharmaceutical company that commercializes products for pain and neurology related disorders.  Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia. CAMBIA® (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks with or without aura in adults (18 years of age or older). Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adults.  Lazanda® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. Gralise and various partner product candidates are formulated with Depomed's proven, proprietary Acuform® drug delivery technology.   Additional information about Depomed may be found at www.depomed.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995.  The statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties including, but not limited to, risks related to the company's ability to acquire or in-license new products and the risks det
'/>"/>

SOURCE Depomed, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Depomed To Present At Piper Jaffray 2013 Healthcare Conference
2. Depomed Reports Third Quarter 2013 Financial Results
3. Depomed To Report Third Quarter Fiscal Year 2013 Financial Results On Tuesday, November 5, 2013
4. Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
5. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
6. Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents
7. Depomed Reports Second Quarter 2013 Financial Results
8. Depomed To Report Second Quarter Fiscal Year 2013 Financial Results On Wednesday, August 7, 2013
9. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
10. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
11. Depomed to Present at Wells Fargo Securities 2013 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Calif. , Sept. 1, 2015 /PRNewswire/ ... cardiovascular image management market, Frost & Sullivan ... 2015 European Frost & Sullivan Award for ... -based PMI has designed innovative and easy-to-use ... deliver precise and reproducible quantitative results for ...
(Date:9/1/2015)... , September 1, 2015 ... company, today announces that it has appointed Hilde ... Non-Executive Directors to its Board of Directors, effective immediately. ... years of experience in pharma and biotech and is ... a Sanofi company. Previously her role was Vice President ...
(Date:9/1/2015)... 1, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... that its affiliate has entered into a collaboration ... an exclusive license to develop and commercialize brodalumab. ... monoclonal antibody in development for patients with moderate-to-severe ... Valeant will hold the exclusive rights to develop ...
Breaking Medicine Technology:Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 2Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 3Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 4Frost & Sullivan Applauds Pie Medical Imaging for Highly Innovative Quantitative Software for Cardiovascular Diagnosis 5BerGenBio Appoints Non-Executive Directors 2Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
... Carol Keehan, DC, president and chief executive officer of ... issued the following statement. The Catholic Health ... for her intelligent and courageous decision to prevent very ... hormone contained in the drug known as Plan B. ...
... The Dr. Paul Janssen Award for Biomedical ... This prestigious award recognizes individuals whose scientific research ... significant transformational contributions toward the improvement of human ... will be accepted until February 15, 2012, for ...
Cached Medicine Technology:Catholic Health Association Applauds HHS Decision on Plan B 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 3Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 4
(Date:9/1/2015)... ... September 01, 2015 , ... Two of Washington D.C.’s most respected chefs are ... dining. , Recently named “the next big thing” in the culinary world by ... the whole story behind food and reclaiming culinary traditions on the brink of extinction. ...
(Date:9/1/2015)... ... 2015 , ... METTLER TOLEDO has announced an upcoming webinar ... , featuring Ed Szczesny (Quality Assurance, Rhodes Pharmaceuticals) as guest presenter. This webinar ... , Calibration, qualification, and the appropriate level of routine testing for laboratory instruments ...
(Date:9/1/2015)... ... 2015 , ... Mercy Health (formerly Catholic Health Partners) – a Catholic healthcare ... Health: Helping You Be Well videos to prostate cancer awareness. Prostate cancer is the ... concise video on Mercy Health’s YouTube channel, Mercy Health experts address issues, such as:, ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... 5:00 to 8:00 pm at the Marriott Indianapolis Downtown, 350 West Maryland Street, ... will be attending from across the country. All specialties will be represented. Attendees ...
(Date:9/1/2015)... ... 01, 2015 , ... Éminence Organic Skin Care is adding ... Peels. This revolutionary collection of natural peel solutions complements the existing routine for ... Formulated with alpha hydroxy acids and natural active ingredients, these results-oriented peels deliver ...
Breaking Medicine News(10 mins):Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 3Health News:PracticeMatch to Host Physician Career Fair at the Marriott Indianapolis Downtown on September 9, 2015 4Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3
... to be effective, they must be taken in the ... healthcare providers. The World Health Organization estimates that half ... health care system and consumers about $300 billion each ... say medication non-adherence interventions should be based on a ...
... potential to alleviate the side effects of cancer treatments. ... at the Frances Payne Bolton School of Nursing at ... medication could ease chemotherapy side effects for people with ... as a nurse practitioner since 1994 at the Cleveland ...
... , MONDAY, Sept. 19 (HealthDay News) -- ... the flu than their northern neighbors due to a public ... 2- to 4-year olds, according to a Canadian-American research team. ... launched by the U.S. Advisory Committee on Immunization Practices in ...
... a new combination treatment for prostate cancer. The treatment, ... now be tested for efficacy in a second phase. ... aggressive form of prostate cancer which has spread to the ... It combines traditional chemotherapy treatments with two doses of ...
... University of New Hampshire finds that the leg strength and ... of normal-weight older women, increasing their risk for disability and ... or obese, the study, published recently in the Journal ... the bird-thin elder being at greatest risk of becoming disabled ...
... the pancreas appear to be talking to each other and ... A small study of obese children enrolled in after-school exercise ... bones, improved insulin sensitivity (reduced diabetes risk) and less of ... researchers report. It also indicated that blood levels of ...
Cached Medicine News:Health News:Integrating medication regimens into daily routines can improve adherence 2Health News:CWRU research examines over-the-counter drug's effect on chemo's side effects 2Health News:U.S. Flu Shot Policy Shields More Kids Than Canada's Program, Study Finds 2Health News:Queen's pioneers prostate cancer breakthrough 2Health News:Study: Overweight older women have less leg strength, power 2Health News:Exercise can produce healthy chatter between bone, fat and pancreatic cells 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
... Hoffmann® II Hybrid External Fixation System ... generation in hybrid fixation. It incorporates ... and is designed to offer speed ... patented Hoffmann® snap-fit technology. , ,Using ...
Versatility of the DFS Standard Fixator provides unsurpassed below-the-ring correction of angular, rotational and translational deformities. Length discrepancy can be precisely corrected in 1/4mm inc...
Medicine Products: